F. Hoffmann-La Roche Ltd. (hereafter 'Roche') [Head Office: Basel, Switzerland. CEO: Severin Schwan] announced its first quarter sales 2022 (January 1 - March 31, 2022).

Roche owns 59.89% of Chugai's outstanding shares (61.16% of voting rights) as of the end of December 2021.

Its investor update and presentation materials can be found on its website (https://www.roche.com/).

Chugai's performance for the period of January 1 to March 31, 2022 is included in the announced Roche Group's results.

Contact:

Media

Chugai Pharmaceutical Co., Ltd.

Media Relations Group

Corporate Communications Dept.,

Tomoko Shimizu

Tel: +81-3-3273-0881

E-mail: pr@chugai-pharm.co.jp

(C) 2022 Electronic News Publishing, source ENP Newswire